Revvity Inc.

Revvity Inc.

PKI

Get informed when a big investor buys or sells

+ Follow
Market Cap$14.46B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Revvity Inc.Revvity Inc.48.50.27%3%4.60.5
$120.14

Current Fair Value

4.3% upside

Undervalued by 4.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$14.46 Billion
Enterprise Value$16.95 Billion
Dividend Yield$0.28 (0.27%)
Earnings per Share$2.07
Beta1.1
Outstanding Shares111,876,000

Return

Return on Equity3.34%ROE
Return on Assets2.00%
Return on Invested Capital3.35%

Valuation & Multiples

P/E Ratio48.54P/E Ratio
PEG-1349.77PEG
Price to Sales4.61Price to Sales
Price to Book Ratio1.8Price to Book Ratio
Enterprise Value to Revenue5.84
Enterprise Value to EBIT46.97
Enterprise Value to Net Income70
Total Debt to Enterprise0.2
Debt to Equity0.47Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0425 421.94%
Total Calls209,500 1147.02%
Total Puts8,900 87.57%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %94.53% 3.10%
Total Invested$10.36B 2.80%
Investors Holding519 12.00%

ESG Score

No data

About Perkinelmer, Inc.

CEO: Prahlad Singh

Relevant Senate Committees

Joint Committee on Taxation

This committee provides the technical analysis and 'scoring' for all tax legislation, directly influencing corporate tax structures, capital investment incentives, and the overall tax burden that impacts Revvity's financial planning and investment decisions.

Finance

As the primary committee for taxation and trade, it directly impacts Revvity's profitability through corporate tax policy, R&D credits, and trade tariffs on imported components or exported instruments, significantly affecting corporate valuations and operations.

Appropriations

This committee controls discretionary federal spending, directly allocating funds for scientific research, defense programs, and health initiatives. These allocations provide direct revenue streams and R&D opportunities for Revvity's products within government labs and research institutions.

Health, Education, Labor, and Pensions

This committee regulates the FDA and NIH. FDA approvals and NIH research funding directly drive demand and R&D activities in the pharmaceutical and biotech sectors, Revvity's primary customer industries. Labor laws also impact manufacturing costs.

Armed Services

This committee oversees the Department of Defense. DoD laboratories engage in extensive R&D (e.g., materials science, chemical/biological analysis) requiring advanced analytical instruments, making DoD a direct potential customer and source of R&D funding for Revvity.

Commerce, Science, and Transportation

With its broad jurisdiction over science and interstate commerce, this committee promotes scientific research and development initiatives, which directly increases the market for Revvity's laboratory instruments. It also oversees agencies relevant to technology and innovation.

Energy and Natural Resources

This committee oversees the Department of Energy, whose national labs are significant users of analytical instrumentation for research. It also impacts the oil and gas and mining sectors, where Revvity's instruments are crucial for analysis and quality control.

Environment and Public Works

This committee regulates the EPA, which sets environmental standards. These standards often require precise analytical testing, directly driving demand for Revvity's environmental monitoring instruments and solutions within regulated industries.